American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV).Washington, DC: APA.
Bifulco, A., Brown, G. W., Moran, P., et al (1998) Predicting depression in women: the role of past and present vulnerability. Psychological Medicine, 28, 39–50.
Brown, G. W. & Harris, T. O. (1989) Life Events and Illness. London: The Guilford Press.
Brown, G. W., Andrews, B., Bifulco, A., et al (1990) Self-esteem and depression. I. Measurement issues and prediction of onset. Social Psychiatry and Psychiatric Epidemiology, 25, 200–209.
Cowen, P. J., Clifford, E. M., Walsh, A. E., et al (1996) Moderate dieting causes 5-HT2 receptor supersensitivity. Psychological Medicine, 26, 1155–1159.
Deakin, J. F. (1988) 5HT2 receptors, depression and anxiety
Pharmacogical Biochemistry and Behaviour, 29, 819–820.
Deakin, J. F. & Graeff, F. G. (1991) 5-HT and mechanisms of defence. Journal of Psychopharmacology, 5, 305–315.
Deakin, J. F., Pennell, I., Upadhyaya, A. J., et al (1990) A neuroendocrine study of 5HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology (Berlin), 101, 85–92.
Dinan, T. G. (1994) Glucocorticoids and the genesis of depressiveillness. A psychobiological model. British Journal of Psychiatry, 164, 365–371.
Dolan, R. J., Calloway, S. P., Fonagy, P., et al (1985) Life events, depression and hypothalamic–pituitary–adrenal axis function. British Journal of Psychiatry, 147, 429–433.
Franklin, M., Cowen, P. J. & Craven, R. D. (1995) The effects of a low tryptophan diet on brain 5-HT metabolism and 5-HT mediated responses in the male rat. Journal of Psychopharmacology, 9, 336–341.
Goodall, E. M., Cowen, P. J., Franklin, M., et al (1993) Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology (Berlin), 112, 461–466.
Goodyer, I. M., Herbert, J., Altham, P. M., et al (1996) Adrenal secretion during major depression in 8— to 16-year-olds. I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychological Medicine, 26, 245–256.
Goodyer, I. M., amplin, A., Herbert, J., et al (2000) Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. British Journal of Psychiatry, 177, 499–504.
Harris, T. O., Borsanyi, S., Messari, S., et al (2000) Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. British Journal of Psychiatry, 177, 505–510.
Kane, J. W. (1979) Use of sodium salicylate as a blocking agent for cort isol binding in radio-immunoassay for cortisol on extracted plasma. Annals of Clinical Biochemistry, 16, 209–212.
Lichtenberg, P., Shapira, B., Gillon, D., et al (1992) Hormone responses to fenfluramine and placebo challenge in endogenous depression. Psychiatry Research, 43, 137–146.
Lopez-Ibor, J. J. Jr., Saiz Ruis, J. & Iglesias, L. M. (1988) The fenfluramine challenge test in the affective spectrum: a possible marker of endogeneity and severity. Pharmacopsychiatry, 21, 9–14.
Maes, M., Jacobs, M. P., Suy, E., et al (1989) Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients. Neuropsychobiology
Maes, M., Calabrese, J. & Meltzer, H. Y. (1994) The relevance of the in— versus outpatient status for studies on HPA-axis in depression: spontaneous hypercortisolism is a feature of major depressed inpatients and not of major depression per se. Progress in Neuropsychopharmacology and Biological Psychiatry, 18, 503–517.
Mitchell, P. & Smythe, G. (1990) Hormonal responses to fenfluramine in depressed and control subjects. Journal of Affective Disorders, 19, 43–51.
Nemeroff, C. B. (1996) The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Molecular Psychiatry, 1, 336–342.
O'Keane, V. & Dinan, T. G. (1991) Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. American Journal of Psychiatry, 148, 1009–1015.
Park, S. B., Williamson, D. J. & Cowen, P. J. (1996) 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine. Psychological Medicine, 26, 1191–1196.
Siever, L., Murphy, D. L., Slater, S., et al (1984) Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sciences, 34, 1029–1039.
Simpson, N. (1984)
Validation of a New Self-Rating Questionnaire to Detect Psychiatric Illness in General Practice: The Personal Health Questionnaire
. MSc Thesis. Victoria: University of Manchester.
Corporation, SPSS (1997) SPSS for Windows. Version 7.5. Chicago, IL: SPSS Inc.
Stokes, P. E., Stoll, P. M., Koslow, S. H., et al (1984) Pretreatment DST and hypothalamic–pituitary–adrenocortical function in depressed patients and comparison groups. A multicenter study. Archives of General Psychiatry, 41, 257–267.
Strickland, P., Morriss, R., Wearden, A., et al (1998) A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. Journal of Affective Disorders, 47, 191–194.
Walsh, A. E., Oldman, A. D., Franklin, M., et al (1995) Dieting decreases plasma tryptophan and increases the prolacton response to d-fenfluramine. Journal of Affective Disorders, 33, 97.
World Health Organization (1992) Schedules for Clinical Assessment in Neuropsychiatry. Geneva: WHO.
World Health Organization (1993) International Classification of Mental and behavioural Disorders – Diagnostic Criteria for Research (10th edn). Geneva: WHO.
Yehuda, R., Giller, E. L. Jr., Levengood, R. A., et al (1995) Hypothalamic–pituitary–adrenal functioning in post-traumatic stress disorder: expanding the concept of the stress response spectrum. In Neurobiological and Clinical Consequences of Stress: From Normal Adaptation to Post-traumatic Stress Disorder (eds Friedman, M. J., Charney, D. S. & Deutch, A. Y.), pp. 351–366. Hagerstown, MD: Lipincott–Raven.